SUPPORTING INFORMATION
(1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one (3.28 g, 0.03 mol) was dissolved in 20.0 mL dry methanol and the mixture was cooled to 0 °C. Thionyl chloride (4.0 g, 2.4 mL, 0.033 mol) was added dropwise (rigorous reaction) to the cooled reaction mixture. After addition, the reaction mixture was stirred to room temperature and kept at that temperature for another 2 hours. Solvent was evaporated under reduced pressure to give the final product as a white solid (5.36 g, 0.03 mol, 100%) without further purification. Methyl (R)-4-(2,5-dimethyl-1H-pyrrol-1-yl)cyclopent-1-ene-1-carboxylate (2b): [i] N COOMe (1R,4S)-Methyl 4-aminocyclopent-2-enecarboxylate hydrochloride salt (2a) (4.0 g, 22.6 mmol) was dissolved in 10.0 mL MeOH. Hexane-2,5-dione (2.64 g, 23.2 mmol) and DIPEA (2.92 g, 22.6 mmol) were added and the mixture was stirred for 16 hours at room temperature. EtOAc (30.0 mL) and sat. aqueous NH4Cl (20.0 mL) were added to the reaction mixture and the two phases partitioned. The aqueous phase was washed with another portion EtOAc and the combined organic phases were washed with brine and dried over MgSO4. The organic phase was later concentrated in vacuo to afford a dark yellow oil. The air sensitive intermediate was immediately subjected to double bond isomerization conditions. For isomerization to 2b, the intermediate (1.0 equiv) was dissolved in 5.0 mL dry THF under nitrogen atmosphere and cooled to 0 °C. 1, .0]undec-7-ene (DBU) (3.0 equiv) in 3.0 mL dry THF was added dropwise and the mixture was stirred at 0 °C for 15 minutes. The reaction was allowed to warm to room temperature and stirred overnight at that temperature. The reaction mixture was diluted with water (30.0 mL) and extracted with EtOAc (2×30.0 mL). The combined organic phases were washed with brine and dried over MgSO4. After filtration, the solvent was removed under reduced pressure. The crude product was purified by column chromatography ( i Hex: EtOAc 80:20) to give a colourless oil (4.0 g, 18.2 mol, 81%). 1 H NMR (CDCl3, 400 MHz) δ 6.89 -6.81 (m, 1H), 5.82 (s, 2H), 5.11 (tt, J = 10.3, 6.5 Hz, 1H), 3.82 (s, 3H), 3.24 -3.03 (m, 2H), 3.03 -2.81 (m, 2H), 2.27 (s, 6H).
13
C NMR (101 MHz, CDCl3) δ 164. 97, 141.07, 134.64, 127.81, 106.50, 52.35, 51.70, 40.38, 38.33, 21.10, 13.96 . *The product turns yellow when exposed to air over time.
General procedure 1 for the synthesis of amides 3a-3j
In a flame dried flask, AlMe3 (2M in toluene, 1.11 mL, 2.18 mmol, 1.2 equiv) was added to 3.0 mL dry toluene under nitrogen atmosphere. The mixture was cooled to 0 °C and 2-iodoaniline (2.0 mmol, 1.1 equiv) in 4.0 mL dry toluene was added. The mixture was stirred for further 5 minutes at 0 °C. The ice bath was removed and the mixture was stirred for further 20 minutes at room temperature. The mixture was cooled to 0 °C again and cyclopentene carboxylate 2b (1.82 mmol, 1.0 equiv) in 3.0 mL dry toluene was added dropwise over 2 minutes to the mixture. After stirring for 10 minutes at 0 °C, the mixture was heated to 60 °C and stirring was continued for 16 hours. After cooling to room temperature, HCl (1M, 8.0 mL) was added. (Caution: gas evaluation, heat development). The mixture was stirred for 15 minutes, then 20.0 mL water and 30.0 mL EtOAc were added. The mixture was extracted, the organic phase was separated and the aqueous phase was re-extracted one more time with 30.0 mL EtOAc. The combined organic phases were washed with brine and dried (MgSO4). The solvent was removed and the crude mixture was purified by column chromatography.
(R)-4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2-iodophenyl)cyclopent-1-ene-1-carboxamide (3a) :
Compound 3a was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (630 mg, 1.55 mmol, 85% 14, 138.78, 137.94, 137.73, 137.57, 129.46, 127.87, 126.04, 121.47, 106.69, 89.98, 52.62, 40.41, 38.39, 14.27 
Compound 3b was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (590 mg, 1.40 mmol, 77%).
1
H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 8.3 Hz, 1H), 7.78 (s, 1H), 7.65 (dd, J = 2.0, 0.9 Hz, 1H), 7.20 (dd, J = 8.4, 2.0 Hz, 1H), 6.83 (h, J = 1.8 Hz, 1H), 5.86 (s, 2H), 5.20 (tt, J = 10.2, 6.5 Hz, 1H), 3.37 -3.26 (m, 1H), 3.22 -3.08 (m, 2H), 3.01 -2.90 (m, 1H), 2.33 (d, J = 0.8 Hz, 3H), 2.31 (s, 6H).
13
C NMR (101 MHz, CDCl3) δ 162. 09, 138.98, 137.75, 129.73, 127.55, 126.98, 121.37, 106.70, 106.40, 90.22, 52.65, 40.41, 38.42, 21.14, 14.29 . HRMS: calcd. for C19H22N2OI [M+H] + 421.0777; found: 421.0767. 09, 142.31, 138.98, 137.75, 133.43, 127.55, 120.30, 117.16, 108.75, 106.70, 88.57, 52.65, 40.41, 38.42, 14.29 
Compound 3d was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (562 mg, 1.32 mmol, 73%). 
C NMR (101 MHz, CDCl3) δ 162. 06, 139.13, 138.87, 138.03, 137.49, 135.62, 127.83, 125.96, 121.21, 106.74, 86.48, 52.56, 40.44, 38.32, 13.78 . HRMS: calcd. for C18H19N2OFI [M+H] + 425.0526; found: 425.0527. 05, 140.44, 137.93, 137.52, 137.20, 132.39, 127.82, 122.11, 117.34, 106.74, 89.97, 52.59, 40.41, 38.33, 13.79 12, 162.06, 139.32, 139.20, 139.10, 138.08, 137.53, 127.82, 113.18, 109.01, 106.80, 82.27, 82.24, 60.44, 52.57, 40.47, 38.35, 13.82 . HRMS: calcd. for C18H19N2OClI [M+H] + 441.0231 ; found: 441.0233.
Compound 3g was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (591 mg, 1.34 mmol, 74%).
1
H NMR (400 MHz, Chloroform-d) δ 8.28 (d, J = 8.9 Hz, 1H), 7.69 (t, J = 2.0 Hz, 2H), 7.31 -7.25 (m, 1H), 6.74 (tt, J = 2.6, 1.6 Hz, 1H), 5.74 (s, 2H), 5.10 (tt, J = 10.2, 6.6 Hz, 1H), 3.25 -3.14 (m, 1H), 3.12 -2.96 (m, 2H), 2.92 -2.82 (m, 1H), 2.19 (s, 6H).
13
C NMR (101 MHz, CDCl3) δ 162. 06, 137.89, 137.81, 137.52, 136.77, 129.90, 129.46, 127.82, 121.71, 106.74, 89.54, 77.36, 77.05, 76.73, 52.59, 40.40, 38.34, 13.79 . HRMS: calcd. for C18H19N2OClI [M+H] + 441.0231; found: 441.0227.
Compound 3h was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (608 mg, 1.35 mmol, 74%). 
C NMR (101 MHz, CDCl3) δ 162. 15, 143.54, 143.51, 139.15, 137.29, 134.23, 134.19, 127.79, 125.14, 119.44, 106.85, 87.64, 52.48, 40.53, 38.29, 13.80 . HRMS: calcd. for C18H19N3O3I [M+H] + 452.0471; found: 452.0466.
Compound 3i was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (571 mg, 1.31 mmol, 72%). 160.74, 138.74, 138.56, 137.82, 137.52, 127.85, 113.21, 106.70, 106.42, 103.82, 77.81, 55.55, 52.62, 40.42, 38.33, 13.79 . HRMS: calcd. for C19H22N2O2I [M+H] + 437.0739; found: 437.0726.
Compound 3j was synthesized according to general procedure 1. After column chromatography (isohexane : EtOAc 4 : 1) a white solid was obtained (548mg, 1.26 mmol, 69%). 08, 156.77, 137.68, 137.11, 131.46, 127.82, 123.84, 122.81, 114.77, 106.69, 91.14, 60.42, 55.73, 52.65, 52.59, 40.37, 38.57, 21.09, 13.80 . HRMS: calcd. for C19H22N2O2I [M+H] + 437.0720; found: 437.0726.
Synthesis of Spirooxindoles a. Method development
To a flame dried reaction vial, Pd(OAc)2, ligand (2 times amount of Pd(OAc)2) and Et3N (0.53 mmol) were added. The vial was evacuated and flushed with nitrogen three times. Dry DMF (1.0 mL) was introduced to the reaction vial and the solution was allowed to stir at room temperature for 10 min. Subsequently, the precursor 3a (0.25 mmol in 0.5 mL dry DMF) was introduced in the reaction mixture and the heating was started. The reaction was left overnight. After completion of the reaction, the reaction mixture was quenched with water (5 mL) and the product was extracted with ethyl acetate (3 x 10 mL). The combined organic layer was washed with a saturated solution of brine and dried over anhydrous MgSO4. The organic extracts were concentrated in vacuo and then passed through a plug of silica and washed with a 1:3 ethyl acetate: iso-hexane solution to remove the palladium source and the ligand. After complete removal of the solvent the crude product was analyzed on 1 H NMR (in DMSO-d6) to determine the conversion and purity of the product.
b. General Procedure 2. Synthesis of Spirooxindoles 4a-4j
To a dried reaction flask, Pd(OAc)2 (3.60 mg, 0.016 mmol), triphenylphosphine (8.39 mg, 0.032 mmol), and Et3N (67.8 mg (0.09mL), 0.67 mmol) were added. The flask was flushed with nitrogen and dry DMF (3.0 mL) was added. The mixture was allowed to stir at room temperature for 10 minutes. Precursor 3 (0.32 mmol) in 2.0 mL dry DMF was added and the reaction allowed to heat to 80 o C. The reaction was allowed to stir at this temperature overnight (assumed as 16 h for convenience). The reaction was later quenched by adding water (10 mL) and extracted with EtOAc (2 x 30 mL). The combined organic layer was washed with brine (10 mL) and dried over anhydrous MgSO4. The organic extracts were concentrated in vacuo and then passed through a plug of silica and washed with a 1:3 ethyl acetate: iso-hexane solution to remove the palladium source and the ligand. The resulting solution was concentrated in vacuo and then analyzed by 1 H NMR. Wherein the regioselectivity was less than 95%, column chromatography was performed on silica (eluted with 7:3 i Hex:EtOAc).
Compound 4a was synthesized according to general procedure 2. After column chromatography (isohexane : EtOAc 7 : 3) a white solid was obtained (77 mg, 0.28 mmol, 86%). 1 H NMR (400 MHz, DMSO-d6) δ 10.53 (s, 1H), 7.27 (dd, J = 7.5, 1.2 Hz, 1H), 7.20 (td, J = 7.7, 1.3 Hz, 1H), 6.98 (td, J = 7.5, 1.1 Hz, 1H), 6.86 (dt, J = 7.7, 0.8 Hz, 1H), 6.28 (dd, J = 5.4, 1.9 Hz, 1H), 5.81 (tt, J = 8.3, 2.4 Hz, 1H), 5.72 (dd, J = 5.4, 2.6 Hz, 1H), 5.62 (s, 2H), 2.56 -2.49 (m, 2H), 2.35 -2.30 (m, 1H), 2.28 (s, 6H). 13 C NMR (101 MHz, DMSO-d6)) δ 180. 06, 141.82, 136.26, 133.72, 133.19, 128.59, 127.91, 123.90, 122.32, 109.95, 106.58, 61.29, 60.34, 42.55, 14.55 . 07, 139.34, 136.07, 133.79, 133.37, 131.27, 128.80, 127.93, 124.49, 109.67, 106.56, 61.34, 60.46, 42.44, 21.15, 14.55 07, 146.32, 137.44, 134.87, 133.93, 131.95, 128.00, 127.76, 119.94, 110.69, 106.60, 104.34, 61.16, 60.14, 42.11, 14.50 
13
C NMR (101 MHz, DMSO-d6) δ 180. 43, 163.84, 161.44, 143.47, 143.35, 136.47, 132.88, 129.51, 127.91, 125.30, 125.20, 108.38, 108.16, 106.60, 98.31, 98.04, 61.20, 59.90, 42.50, 14.43 72, 141.21, 137.04, 136.22, 132.41, 131.32, 128.00, 126.88, 114.13, 111.85, 106.54, 61.23, 60.68, 42.11, 14.54 
Compound 4f was synthesized according to general procedure 2. After column chromatography (isohexane : EtOAc 7 : 3) a white solid was obtained (74 mg, 0.24 mmol, 74%). 02, 143.38, 136.76, 132.82, 132.67, 132.60, 127.91, 125.43, 121.93, 110.01, 106.61, 61.20, 60.02, 42.37, 40.61, 40.40, 40.19, 39.98, 39.78, 39.57, 39.36, 14.44 
C NMR (101 MHz, DMSO-d6) δ 179. 94, 155.69, 136.40, 135.11, 135.06, 133.10, 127.95, 112.96, 111.34, 110.21, 106.53, 61.24, 60.86, 56.08, 55.37, 42.49, 14.56 64, 160.13, 142.96, 135.84, 133.40, 127.89, 125.52, 124.56, 107.14, 106.56, 96.97, 61.21, 59.83, 55.72, 42.69, 14.45 o C for 60 min. After cooling, built up gas was slowly released and water (10 mL) was added. The mixture was extracted twice with EtOAc (2 x20 mL) washed with more water (3 x 20 mL) and the combined organic phases were dried with MgSO4. The resulting crude was purified by column chromatography (eluting with 7:3 i Hex:EtOAC), to afford a white solid (271 mg, 0.66 mmol, 66%). 72, 166.12, 144.55, 137.09, 136.09, 133.35, 131.78, 131.18, 128.65, 128.55, 128.35, 128.20, 124.98, 124.88, 109.66, 106.57, 66.78, 61.22, 60.19, 42.46, 14.29 
C NMR (101 MHz, DMSO-d6) δ 180. 48, 167.69, 146.24, 136.88, 133.86, 132.69, 131.14, 127.97, 124.89, 124.87, 109.76, 106.59, 61.43, 60.32, 42.29, 14.50 Benzyl (1R,4S)-4-amino-2'-oxospiro[cyclopentane-1,3'-indolin]-2-ene-5'-carboxylate (9):
A reaction vial was loaded with n-hydroxylamine hydrochloride (100 mg, 1.44 mmol), potassium hydroxide (54 mg, 0.96 mmol) and protected amine 7 (100 mg, 0.24 mmol). Next, 3 mL MeOH : H2O (3 : 1) was added and the reaction heated to 90 o C and stirred at that temperature for 24 h. The reaction mixture was concentrated and the resulting solution was purified by preparative HPLC (gradient of 5-100%) in 0.05% HCOOH in H2O and 0.05% HCOOH in MeCN to yield a brown solid (41 mg, 0.12mmol, 51%). 1 H NMR (400 MHz, Methanol-d4) δ 7.93 (dd, J = 8.2, 1.7 Hz, 1H), 7.72 (d, J = 1.7 Hz, 1H), 7.35 -7.30 (m, 2H), 7.30 -7.20 (m, 3H), 6.96 (d, J = 8.2 Hz, 1H), 6.24 (dd, J = 5.5, 2.4 Hz, 1H), 5.87 (dd, J = 5.5, 0.7 Hz, 1H), 5.22 (s, 2H), 4.52 (dt, J = 7.2, 2.6 Hz, 1H), 2.56 (dd, J = 14.5, 7.3 Hz, 1H), 2.23 (dd, J = 14.6, 2.0 Hz, 1H).
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